Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Connected Car Data: Your Vehicle's True Emissions
We live in a world where the process of simply getting from point A to point B has been completely transformed.
Workers' Comp
Article
CMS Releases Version 2.9 of WCMSA Reference Guide
Keep current with new legislation and its potential effect on your organization.
Disability
White Paper
A Higher Bar for Quality Under ERISA’s New Rule
Today, a primary concern of executives at disability insurance carriers is compliance with updates to the Employee Retirement Income Security Act (
Workers' Comp
News Release
Genex Services Acquires Excel Managed Care, Expands Clinical Services
Combination of industry leaders will further enhance quality of case management and utilization review in workers' compensation and disability ser
Mitchell
News Release
Montana Publishes Adopted Drug Formulary Rule
After an extensive and inclusive rulemaking process involving multiple stakeholder meetings and comment periods, the Montana Department of Labor an
Workers' Comp
Article
Medicare proposed rulemaking and enhancements to the MSP Recovery Portal
Keep current with new legislation and its potential effect on your organization.